Thalys Medical Technology Group Corporation (SHA:603716)
China
· Delayed Price · Currency is CNY 21.06
+0.15 (0.72%)
Apr 29, 2026, 3:00 PM CST
SHA:603716 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -204.64 | -201.44 | -209.24 | -158.57 | -153.73 | -49.51 | Upgrade
|
| Depreciation & Amortization | 44.05 | 44.05 | 50.99 | 74.71 | 84.35 | 96.28 | Upgrade
|
| Other Amortization | 7.25 | 7.25 | 11.59 | 9.7 | 23.22 | 19.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | 0.25 | -7.62 | 2.54 | 0.02 | -0.4 | Upgrade
|
| Asset Writedown & Restructuring Costs | 59.62 | 59.62 | 24.18 | 35.91 | 19.18 | 0.72 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.67 | -5.67 | 68.01 | 11.3 | 31.8 | 25.66 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -38.53 | 28.17 | 91.54 | 62.11 | Upgrade
|
| Other Operating Activities | 62.71 | 23.28 | 77.83 | 129.87 | 64.36 | 110.78 | Upgrade
|
| Change in Accounts Receivable | -32.03 | -32.03 | 65.62 | 5.19 | -171.05 | -457.83 | Upgrade
|
| Change in Inventory | 102.78 | 102.78 | 15.44 | 79.15 | 42.89 | -61.16 | Upgrade
|
| Change in Accounts Payable | -74.18 | -74.18 | 11.43 | -16.88 | 39.91 | 151.89 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | -4.58 | -2.64 | Upgrade
|
| Operating Cash Flow | -1.52 | -37.75 | 99.6 | 125.89 | 28.12 | -133.52 | Upgrade
|
| Operating Cash Flow Growth | - | - | -20.89% | 347.65% | - | - | Upgrade
|
| Capital Expenditures | -5.13 | -5.72 | -23.21 | -40.83 | -54.64 | -60.19 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.21 | 0.13 | 0.54 | 0.31 | 0.24 | 14.44 | Upgrade
|
| Divestitures | 5.17 | 40.4 | 27.49 | -4.94 | -16.73 | 2.65 | Upgrade
|
| Investment in Securities | -43.89 | -29.68 | -12.49 | 49.12 | 121.62 | -77.63 | Upgrade
|
| Other Investing Activities | 19.29 | 25.08 | 0 | 11.52 | 109.22 | 6 | Upgrade
|
| Investing Cash Flow | -24.36 | 30.21 | -7.67 | 15.19 | 159.71 | -114.72 | Upgrade
|
| Long-Term Debt Issued | - | 317.83 | 443.05 | 892.36 | 1,235 | 1,112 | Upgrade
|
| Long-Term Debt Repaid | - | -326.7 | -516.38 | -1,075 | -1,494 | -962.8 | Upgrade
|
| Net Debt Issued (Repaid) | 37.01 | -8.87 | -73.33 | -182.17 | -259.4 | 149.39 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1.59 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -29.72 | - | - | -50.27 | Upgrade
|
| Common Dividends Paid | -18.06 | -18.56 | -59.88 | -38.8 | -52.25 | -49.52 | Upgrade
|
| Other Financing Activities | -31.37 | -50.41 | 14.66 | 6.66 | -6.58 | 11.78 | Upgrade
|
| Financing Cash Flow | -12.41 | -77.84 | -148.27 | -214.31 | -316.64 | 61.39 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0 | 0 | -0.04 | 0.03 | -0.03 | Upgrade
|
| Net Cash Flow | -38.28 | -85.38 | -56.35 | -73.26 | -128.78 | -186.88 | Upgrade
|
| Free Cash Flow | -6.66 | -43.47 | 76.39 | 85.06 | -26.52 | -193.71 | Upgrade
|
| Free Cash Flow Growth | - | - | -10.20% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -0.69% | -4.04% | 4.22% | 4.24% | -1.15% | -7.45% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.22 | 0.40 | 0.44 | -0.14 | -0.98 | Upgrade
|
| Cash Income Tax Paid | 66.53 | 76.66 | 96.78 | 110.37 | 150.82 | 139.56 | Upgrade
|
| Levered Free Cash Flow | 261.3 | 292.76 | 231.71 | 375.96 | 236.34 | -184.22 | Upgrade
|
| Unlevered Free Cash Flow | 265.05 | 292.76 | 267.76 | 423.58 | 298.07 | -132.49 | Upgrade
|
| Change in Working Capital | 34.91 | 34.91 | 122.38 | -7.73 | -132.63 | -398.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.